Modulating antibody N-glycosylation through feed additives using a multi-tiered approach
Frontiers in Bioengineering and Biotechnology · 26.08.2024 · 12
DOI: 10.3389/fbioe.2024.1448925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 26.08.2024. Verfasst von Jaka Kranjc und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glycosylation of recombinant proteins is a post-translational modification that affects multiple physicochemical and biological properties of proteins. As such, it is a critical quality attribute that must be carefully controlled during protein production in the pharmaceutical industry. Glycosylation can be modulated by various conditions, including the composition of production media and feeds. In this study, the N-glycosylation-modulating effects of numerous compounds, including metal enzyme cofactors, enzyme inhibitors, and metabolic intermediates, were evaluated. Chinese hamster ovary cells producing three different IgG antibodies were cultivated in a fed-batch mode. First, a one-factor-at-a-time experiment was performed in 24-well deep well plates to identify the strongest modulators and appropriate concentration ranges. Then, a full response surface experiment was designed to gauge the effects and interactions of the 14 most effective hit compounds in an Ambr ® 15 bioreactor system. A wide range of glycoform content was achieved, with an up to eight-fold increase in individual glycoforms compared to controls. The resulting model can be used to determine modulator combinations that will yield desired glycoforms in the final product.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pharmacy, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
- Cell Line Engineering and Characterization, Technical Research & Development, Novartis Pharmaceutical Manufacturing LLC, Mengeš, Slovenia.
- Process Analytical Science, Technical Research & Development, Novartis Pharmaceutical Manufacturing LLC, Mengeš, Slovenia.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
- Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
- Process Development, Technical Research & Development, Novartis Pharmaceutical Manufacturing LLC, Mengeš, Slovenia.
Zitieren
APA
Kranjc, J., Kramer, L., Mikelj, M., Anderluh, M., Pišlar, A., & Brinc, M. (2024). Modulating antibody N-glycosylation through feed additives using a multi-tiered approach. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1448925
Vancouver
Kranjc J, Kramer L, Mikelj M, Anderluh M, Pišlar A, Brinc M. Modulating antibody N-glycosylation through feed additives using a multi-tiered approach. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1448925
BibTeX
@article{Kranjc2024,
author = {Kranjc, Jaka and Kramer, Lovro and Mikelj, Miha and Anderluh, Marko and Pišlar, Anja and Brinc, Matjaž},
title = {Modulating antibody N-glycosylation through feed additives using a multi-tiered approach},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2024},
volume = {12},
doi = {10.3389/fbioe.2024.1448925}
}
EUVIMED